Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/882"

PredicateValue (sorted: default)
rdfs:label
"evidence_1102"
rdf:type
?:Evidence
?:Item
?:Evidence_enzyme_system
""
?:Evidence_type
?:EV_EX_Met_Enz_ID_Cyp450_Hum_Recom
?:content
"Enzyme system: recombinant human enzymes in human lymphoblastoid cells NADPH added:yes inhibitor used: no Table 2 shows that CYP2C19, CYP2B6, CYP2A6, AND CYP3E1 each contributed less than 1% to the formation of metabolites by the three metabolic pathways examined. NOTE: Formation of MIR-N+-glucuronide, a metabolite found in significant concentrations in humans, was not examined however, this metabolite is likely the product of the either the dirct glucuronidation of mirtazapine or a metabolite produced by the three pathways examined."
dc:creator
"boycer"
dc:date
"02132010"
rdfs:seeAlso
?:10997935

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ mirtazapine_is_not_substrate_of_cyp2b6, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1102 }

Context graph